Salicylic Acid

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the removal of corns and calluses. It provides relief from pain associated with these conditions by effectively removing the corns and calluses.

There are no teratogenic or nonteratogenic effects mentioned in the available data.

Dosage and Administration

The affected area should be washed and dried thoroughly prior to application. One drop of the product should be applied at a time using the provided applicator, ensuring that each corn or callus is sufficiently covered. After application, the area should be allowed to dry completely.

To relieve pressure on the treated area, it is recommended to use cushions with a hole centered over the corn or callus. Additional cushions may be purchased separately if needed.

This procedure may be repeated once or twice daily as necessary, for a maximum duration of 14 days, or until the corn or callus is removed.

Contraindications

Use is contraindicated in the following situations:

Application on irritated skin is prohibited due to the potential for exacerbation of the condition. The product should not be applied to any area that is infected or reddened, as this may lead to further complications. Additionally, use is contraindicated in patients with diabetes, given the increased risk of adverse effects. Patients with poor blood circulation should also avoid use, as this may impair healing and increase the risk of complications.

Warnings and Precautions

For external use only, this product is flammable; therefore, it must be kept away from fire or flame. It is essential to cap the bottle tightly and store it at room temperature, away from heat sources.

This product should not be used on irritated skin or on any area that is infected or reddened. Additionally, individuals with diabetes or poor blood circulation should refrain from using this product.

When utilizing this product, if discomfort persists, it is advised to consult a healthcare professional, such as a doctor or podiatrist. Care should be taken to avoid contact with the eyes and to prevent inhalation of vapors. In the event that the product comes into contact with the eyes, it is crucial to flush the eyes with water for at least 15 minutes.

To ensure safety, this product must be kept out of reach of children. In the case of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center should be made without delay.

Side Effects

Patients should be aware that this product is for external use only. It is contraindicated for use on irritated skin, any area that is infected or reddened, and in individuals with diabetes or poor blood circulation.

During the use of this product, if discomfort persists, patients are advised to consult their doctor or podiatrist. It is important to avoid contact with the eyes and to refrain from inhaling vapors. In the event that the product comes into contact with the eyes, it should be flushed with water for 15 minutes.

Additionally, this product should be kept out of reach of children. If swallowed, patients should seek medical assistance or contact a Poison Control Center immediately.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Salicylic Acid (liquid corn and callus remover). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. As such, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

The use of salicylic acid is contraindicated in pregnant patients or those planning to become pregnant. The safety of salicylic acid during pregnancy has not been established, and its use should be considered only if clearly needed, with a careful assessment of the potential benefits versus the risks to the fetus. Healthcare professionals are advised to counsel women of childbearing potential regarding these risks and to explore alternative treatment options when appropriate.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or its effects on lactation. Additionally, no data are provided concerning the excretion of the drug in breast milk or its potential effects on breastfed infants. Healthcare professionals should consider the lack of information when advising lactating mothers about the use of this medication.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the drug insert text regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of data necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved, and healthcare providers should be prepared to assess and manage these symptoms accordingly.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are recommended to ensure patient safety and effective resolution of any complications arising from the overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Patients should be informed not to use the product on irritated skin or on any area that is infected or reddened. It is also important to counsel patients against using the product if they are diabetic or have poor blood circulation, as these conditions may increase the risk of adverse effects.

While using the product, patients should be advised to monitor for any discomfort. If discomfort persists, they should consult their doctor or podiatrist for further evaluation.

Healthcare providers should emphasize the importance of avoiding contact with the eyes and inhaling vapors from the product. In the event that the product does come into contact with the eyes, patients should be instructed to flush the eyes with water for at least 15 minutes and seek medical attention if irritation continues.

Storage and Handling

The product is supplied in a tightly capped bottle. It is essential to store the bottle at room temperature, ensuring it is kept away from heat sources. The recommended storage temperature range is between 20°C to 30°C (68°F to 86°F). Additionally, it is crucial to keep the product away from fire or flame to maintain safety and integrity.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Salicylic Acid, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)